IFS Advisors’s Pfizer PFE Stock Holding History

IFS Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.8K	Hold	1,820	–	–	0.02%	62
2026 Q1	$51.1K	Hold	1,820	–	–	0.03%	52
2025 Q4	$45.3K	Hold	1,820	–	–	0.02%	51
2025 Q3	$46.4K	Hold	1,820	–	–	0.03%	48
2025 Q2	$44.1K	Sell	1,820 -2,166	-54%	-$50.5K	0.03%	42
2025 Q1	$101K	Buy	3,986 +293	+8%	+$7.67K	0.08%	25
2024 Q4	$98K	Buy	3,693 +3,277	+788%	+$88.9K	0.08%	23
2024 Q3	$12K	Hold	416	–	–	0.01%	60
2024 Q2	$11.6K	Hold	416	–	–	0.01%	58
2024 Q1	$11.5K	Hold	416	–	–	0.01%	58
2023 Q4	$12K	Hold	416	–	–	0.01%	51
2023 Q3	$13.8K	Hold	416	–	–	0.03%	46
2023 Q2	$15.3K	Hold	416	–	–	0.04%	40
2023 Q1	$17K	Hold	416	–	–	0.07%	35
2022 Q4	$21.3K	Hold	416	–	–	0.04%	33
2022 Q3	$18K	Hold	416	–	–	0.03%	33
2022 Q2	$21K	Hold	416	–	–	0.06%	29
2022 Q1	$21K	Hold	416	–	–	0.02%	37
2021 Q4	$24K	Buy	+416	New	+$20.6K	0.02%	46
2021 Q1	–	Sell	-916	Closed	-$33K	–	113
2020 Q4	$33K	Buy	+916	New	+$33.6K	0.03%	57

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IFS Advisors's PFE Position: Q2 2026 in Review

IFS Advisors held its Pfizer (PFE) position steady in Q2 2026 at 1,820 shares worth $43.8K. The position accounts for 0.02% of the portfolio, ranked #62.

IFS Advisors first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $101K in Q1 2025. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

IFS Advisors held 1,820 shares of Pfizer worth $43.8K as of Q2 2026.
IFS Advisors left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.02% of IFS Advisors's portfolio in Q2 2026, its #62 holding.
IFS Advisors first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
IFS Advisors's Pfizer position peaked at $101K in Q1 2025.
2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IFS Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.